| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 33.56 Billion | USD 149.35 Billion | 16.1% | 2024 |
FrequentlyAsked Questions
Purification and recovery of biosynthetic and medicinal compounds obtained from natural sources are referred to as downstream processing.
The global downstream processing market is expected to grow due to increasing biopharmaceutical production, technological advances, and growing demand for monoclonal antibodies and vaccines.
According to a study, the global downstream processing market size was worth around USD 33.56 Billion in 2024 and is expected to reach USD 149.35 Billion by 2034.
The global downstream processing market is expected to grow at a CAGR of 16.1% during the forecast period.
North America is expected to dominate the downstream processing market over the forecast period.
Leading players in the global downstream processing market include Sartorius AG, GE Healthcare, Merck KGaA, Thermofisher Scientific, Danaher, Repligen Corporation, 3M, Boehringer Ingelheim International GmbH, Corning Incorporated, Lonza, Dover Corporation, Asahi Kasei Corporation, Eppendorf SE, among others., among others.
The report explores crucial aspects of the downstream processing market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients